Should you build or buy Test Automation (Functional & AI-Augmented)?

Test automation software (functional and AI-augmented) writes, runs, and maintains automated checks against web, mobile, and enterprise applications, using record-and-playback authoring, self-healing locators, cross-browser grids, and increasingly AI-generated test steps. Buyers are QA and engineering teams choosing between commercial platforms and open-source frameworks like Playwright and Selenium.

For web products with an engineering team, standardize on Playwright and own the framework, CI and reporting; treat AI generation and healing as reviewed changes to tests, not autonomous maintenance. Keep or buy a commercial platform where SAP/ERP process depth, business-user codeless authoring or physical-device breadth is worth the subscription, and rebid the rest at renewal.

Build it, buy it, or bridge?

⚒ Build it
✓ Buy it
➔ Bridge
Cost shape
A maintained Playwright framework's modeled three-year cost includes real engineering time
A five-seat commercial package models cheaper on paper over the same period
Buy for SAP/ERP or device breadth; build the web regression suite your engineers already own
Time to value
n8n and FundGuard already run production Playwright suites; framework setup takes weeks, not months
Katalon, mabl, and Tosca provide codeless authoring usable on day one for non-engineers
Start with Playwright for web coverage; add a commercial tool only where SAP depth is needed
Differentiation captured
None — testing confers no competitive edge regardless of who owns the framework
None here either; vendors sell breadth and usability, not a testing advantage
Neither side captures differentiation; the split is about who's easiest to maintain
AI feasibility today
AI coding tools now draft and self-heal Playwright tests well enough for production use.
Commercial platforms bundle the same AI test generation, so buying adds usability, not capability.
Use AI to draft your Playwright suite. Buy only for SAP depth or device breadth.
Who it fits
Engineering teams with web products who want to own their CI and reporting
Teams testing SAP/ERP processes, needing thousands of device combinations, or lacking engineering capacity
Most teams: own the Playwright core, keep a commercial license for the specific gap

When building makes sense

Self-built Playwright frameworks are the documented mainstream choice for engineering-owned web regression testing, and this is the stronger case in this category. n8n moved off Cypress and cut flakiness from 2-3% down to 0.3%; Juvare, Runa, and FundGuard run production Playwright suites, with FundGuard cutting CI cost 70% using spot instances; Business Insider and Firstbase run theirs at scale, and one documented migration moved 50,000 Selenium tests to Playwright. AI-assisted generation and self-healing now ship inside the open-source framework itself: Microsoft's Azure DevOps team generated hundreds of tests with Copilot and the Azure DevOps MCP server under human review, and Playwright's own planner, generator, and healer agents produce tests that still need a reviewer to correct. A modeled three-year comparison didn't clearly favor building on cost alone against a comparable commercial package; the argument for building is engineering ownership and flexibility, not guaranteed savings.

When buying makes sense

Buying still earns its place where the commercial platform's specific depth matters. Tricentis Tosca's model-based testing handles SAP and ERP process depth that a Playwright script doesn't reach without heavy custom work; Sauce Labs offers thousands of browser and OS combinations plus real devices that would be expensive to replicate; Katalon and mabl give non-technical testers codeless authoring that keeps QA out of the engineering backlog. This isn't a capability gap in the sense that the tests themselves are hard to write — it's that these platforms package breadth, device access, or business-user usability that a self-built framework has to earn separately. Keep or buy a commercial platform for SAP/ERP testing, physical device coverage, or teams without engineering capacity to own a framework, and rebid plain web regression at renewal, since the open-source alternative now covers the same core capability your license is charging for.

The desk read

Build-versus-buy analysis for Test Automation (Functional & AI-Augmented) is being written. In the meantime, the framework that drives every B4 call is on the B4 Index page.

Representative vendors Katalon Platformmabl + 4 more, listed in the full index

Frequently asked

Can you replace a commercial test automation platform with Playwright?

For web regression, yes. n8n, Juvare, Runa, and FundGuard all run self-built Playwright frameworks in production, and one documented migration moved 50,000 Selenium tests over. The gap that remains is SAP/ERP process depth and physical device breadth, which commercial platforms still cover better.

How good is AI-generated testing right now?

Good enough to draft, not to trust unsupervised. Microsoft's Azure DevOps team generated hundreds of Playwright tests with Copilot under human review, and Playwright's own agents flag that generated tests typically need correction. Treat AI output as a first draft.

What are the main test automation vendors?

Representative vendors include Katalon Platform, mabl. B4 Pro includes the category score and the full vendor list.

The B4 Index scores every software category on two axes, strategic differentiation and AI feasibility, to classify it Build, Buy, Bridge, or Beware. See the full methodology.

More in Dev & Engineering

Build or buy DevOps Platform? Build or buy CI/CD? Build or buy Version Control? Build or buy Low-Code / No-Code? Build or buy Infrastructure as Code (IaC)? Build or buy iPaaS? Build or buy API Management? Build or buy SAST? Build or buy DAST? Build or buy Code Quality Analysis? Build or buy Container Registry? Build or buy Release Orchestration?